ArticleHemaSphere2025

Inhibition of the NLRP3 inflammasome using MCC950 reduces vincristine-induced adverse effects in an acute lymphoblastic leukemia patient-derived xenograft model.

Hana Starobova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.